Analysis of pathophysiology of intestinal graft-versus-host disease after HLA-haploidentical stem cell transplantatio
Not Applicable
Recruiting
- Conditions
- Diseases that are treated with allogeneic stem cell transplantation, including acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic syndrome, chronic myeloid leukemia, chronic lymphoid leukemia, myeloproliferative disorder, multiple myeloma, aplastic anemia, etc.
- Registration Number
- JPRN-UMIN000006648
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify parameter of intestinal GVHD following HLA-haploidentical stem cell transplantation
- Secondary Outcome Measures
Name Time Method 1. Impact of TMA and viral infections on intestinal symptoms after haploidentical stem cell transplantation. 2. To identify the best therapy of intestinal GVHD. 3. The usefulness of PET/CT scan for the diagnosis of intestinal GVHD